COVID-19 has caused a worldwide pandemic, accompanied by a high number of deaths and hospitalizations. Multiple preventative vaccines and variety of COVID-19 treatments have been developed and explored. This large volume of scientific work led to an extensive number of COVID-19 publications, which resulted in the necessity to standardize, store, share, and investigate research results in a harmonized manner. Attempts to standardize and share COVID-19 research data have been lacking. The purpose of the ReMeDy platform is to provide an intelligent informatics solution of integrating diverse COVID-19 trial outcomes and omics data across COVID-19 research studies. To test the platform, we utilized 48 COVID-19 observational retrospective studies. The robustness of the platform was validated through the ability to efficiently organize the diverse data elements. Next steps include expanding our database through the inclusion of all published COVID-19 studies. ReMeDy is located at https://remedy.mssm.edu/.
©2022 AMIA - All rights reserved.